Saturday, 21 May, 2022
TopicDCGI

Topic: DCGI

DCGI gives nod to Biological E’s Covid vaccine phase 2/3 clinical trials on 5-18 year olds

The trial will be conducted across 10 sites in India. Zydus Cadila's ZyCoV-D is so far the only vaccine to get Emergency Use Authorisation in the 12-18 years age group in India.

Zydus Cadila applies for approval to ZyCov-D, India’s 1st Covid vaccine tested on 12-18-yr-olds

If ZyCov-D gets the approval, it will be the fifth vaccine authorised for use in India after Covishield, Covaxin, Sputnik V and Moderna.

Drug regulator says no need for bridging trials on foreign approved vaccines before India roll out

DCGI modifies earlier order on emergency approval of well-established vaccines, waives several requirements, but retains assessment of first 100 beneficiaries before proper roll out.

DCGI approves anti-Covid drug developed by DRDO for emergency use

The drug has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of DRDO, in collaboration with Dr Reddy's Laboratories in Hyderabad.

DCGI to take decision on emergency use applications for foreign Covid vaccines in 3 days

The DCGI will issue permission for restricted emergency use on the condition that the vaccine be used according to guidelines under the National Covid-19 Vaccination Programme.

DCGI approves Russian Covid vaccine Sputnik for restricted emergency use in India

Sputnik V is to be administered intramuscularly to individuals aged 18 yrs & above in two doses of 0.5 ml each with an interval of 21 days.

Drug regulator DCGI extends shelf life of Covishield vaccine from 6 to 9 months

In a letter to the Serum Institute, Drugs Controller General of India Somani said the institute is permitted to apply the shelf life of 9 months to unlabeled vials available on hand.

‘No uniform test for cancer-causing substances in J&J baby products’ — drug regulator summoned

Child rights body issues summons over lack of standard testing methods to screen for presence of formaldehyde and asbestos in Johnson & Johnson’s baby shampoo and talcum powder.

Zee News on vaccine approval, Times Now on ‘green shoots’ in Indian economy

A quick take on what prime time TV news talked about.

Serum expects govt to sign pricing deal for Covishield within days

Officials have 'indicated orally' that first 100mn vaccines will be purchased at Rs 200 & a deal should be inked 'in next one or two days', according to Serum CEO Adar Poonawalla.

On Camera

YourTurn

Representative image of an ethanol-blended fuel station plug | Wikimedia Commons

Ethanol blended fuel to power vehicles. Will it hurt your car’s engine?

India’s reliance on ethanol blended fuel is only set to increase in the wake of rising crude oil prices. But are we going to adapt in time?
A shopkeeper arranges stock at a grocery store in Bengaluru | Representational image | Bloomberg Photo

Inflation raised monthly expenses of 92% Indian families in last 3 months, finds online survey

A LocalCircles poll found that 70% of respondents felt their monthly household budget increased by 10% while 55% expected expenses to go up by another 10% in the next 3 months.

Defence

File photo of a defence personnel armed with a SiG 716 rifle near the Line of Control | Photo: Snehesh Alex Philip | ThePrint

India to ink ‘repeat order’ deal for 73,000 SiG 716 rifles from the US

In February 2019, 72,400 SiG 716 rifles of 7.62 x 51mm calibre were contracted from SIG Sauer Inc, USA, under government's 'Buy (Global) category', through fast track procedure.

How Congress is like the Ambassador & why Indian politics needs a brand new set of wheels

Like the car, nothing the party has done to reinvent itself has worked. Only way forward is to offer something looking towards the future, not in image of glorious past.
×